NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed)
ID: 355096Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Jun 24, 2024 12:00 AM
  4. 4
    Due Jul 12, 2027 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed)". This grant aims to support new and talented, independent investigators from diverse backgrounds conducting research on Alzheimer's disease and Alzheimer's Disease-Related Dementias (AD/ADRD). The program is designed to facilitate the transition of promising postdoctoral researchers to independent, tenure-track or equivalent faculty positions in the AD/ADRD field. The grant provides independent NIH research support during this transition to help awardees establish independent research programs. This specific funding opportunity is for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants are allowed to propose research experience in a clinical trial led by a mentor or co-mentor. For more information and to apply, visit the following link: Additional Information.

Point(s) of Contact
Files
Title
Posted
Similar Opportunities
NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "NINDS Alzheimer's Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)". This grant aims to support new and talented, independent investigators from diverse backgrounds conducting research on Alzheimer's disease and Alzheimer's Disease-Related Dementias (AD/ADRD). The program is designed to facilitate the transition of promising postdoctoral researchers to independent, tenure-track or equivalent faculty positions in the AD/ADRD field. The grant provides independent NIH research support during this transition to help awardees establish independent research programs. The grant does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants are allowed to propose research experience in a clinical trial led by a mentor or co-mentor. For more information and to apply, visit the NIH grants website at [http://grants.nih.gov/grants/guide/pa-files/PAR-24-212.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-212.html).
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)". This grant aims to promote the development of a diverse, interdisciplinary workforce for conducting translational research on Alzheimer's disease and related dementias. The grant will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds in basic biology, translational and clinical research, and data science. The program seeks to provide trainees with the necessary knowledge and skills in data science, disease biology, behavioral research, and drug discovery disciplines to conduct rigorous and cutting-edge research for Alzheimer's disease and related dementias. Eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). The grant does not require cost sharing or matching. The closing date for applications is September 25, 2026. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-121.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-121.html). For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) grant. This grant aims to support the transition of outstanding postdoctoral researchers with a clinical doctorate degree to independent, tenure-track or equivalent faculty positions. The program provides independent NIAID research support to help awardees launch competitive, independent research careers in biomedical fields and address the national physician-scientist workforce shortage. The grant does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. However, candidates are allowed to propose a research experience in a clinical trial led by a mentor or co-mentor. For more information, visit the [grant announcement](https://grants.nih.gov/grants/guide/pa-files/PAR-23-071.html).
Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Early and Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)". This grant aims to support the development and implementation of clinical trials for cognitive and neuropsychiatric changes associated with age-related cognitive decline, Alzheimer's disease (AD), and Alzheimer's disease-related dementias (ADRD). The trials will cover the entire spectrum of the disease, from pre-symptomatic to more severe stages. The funding will be used to explore both pharmacological and non-pharmacological interventions. The NIH is particularly interested in proposals that enhance trial design and methods. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is January 7, 2025. For more information and to apply, visit the NIH grants website at [http://grants.nih.gov/grants/guide/pa-files/PAR-23-081.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-081.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)". This grant aims to support the development and implementation of clinical trials for pharmacological and non-pharmacological interventions to prevent and treat the cognitive, behavioral, and neuropsychiatric changes associated with age-related cognitive decline, Alzheimer's disease (AD), and Alzheimer's disease-related dementias (ADRD). The grant also aims to stimulate studies that enhance trial design and methods. The funding instrument for this opportunity is a grant, and there is no cost sharing or matching requirement. The category of funding activity is health, and the opportunity falls under the discretionary category. The CFDA number associated with this grant is 93.866. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the federal government, faith-based or community-based organizations, Hispanic-serving institutions, historically Black colleges and universities (HBCUs), Indian/Native American tribal governments, non-domestic entities (foreign organizations), regional organizations, tribally controlled colleges and universities (TCCUs), and U.S. territories or possessions. The closing date for applications is October 17, 2024, and the archive date is November 22, 2024. For more information and to apply, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-011.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-011.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.